Chuifeng Fan
Shenyang, 110001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Furmonertinib-based triplet therapy improves survival in EGFR-mutant NSCLC with leptomeningeal metastases: a large-scale multicenter retrospective study (FURMO-LM).
Journal: ESMO open
Published: December 03, 2025
Nit1 is upregulated in non-small cell lung cancer and promotes cancer cell proliferation and invasion and regulates EMT-related molecules and cyclins.
Journal: Journal of Cancer
Published: March 08, 2025
Ossifying fibromyxoid tumor of the soft tissue in the left upper arm and a review of the literature: A case report.
Journal: Experimental and therapeutic medicine
Published: December 19, 2023
Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial.
Journal: ESMO open
Published: October 26, 2023
Multiple Primary Lung Tumors of Different Pathological Types Including Squamous Cell Carcinoma, Adenocarcinoma, and Mixed Squamous Cell and Glandular Papilloma: A Case Report.
Journal: OncoTargets and therapy
Published: October 21, 2021
The Role of Ki67 in Evaluating Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer.
Journal: Frontiers in endocrinology
Published: March 29, 2021
ATF4 promotes lung cancer cell proliferation and invasion partially through regulating Wnt/β-catenin signaling.
Journal: International journal of medical sciences
Published: December 17, 2020
WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression.
Journal: Cell death & disease
Published: December 05, 2020
Timescale of tumor volume of a young breast cancer patient with luminal B subtype: A case report.
Journal: Medicine
Published: October 26, 2019
Ube2S regulates Wnt/β-catenin signaling and promotes the progression of non-small cell lung cancer.
Journal: International journal of medical sciences
Published: September 12, 2019
FAM163A, a positive regulator of ERK signaling pathway, interacts with 14-3-3β and promotes cell proliferation in squamous cell lung carcinoma.
Journal: OncoTargets and therapy
Published: May 07, 2019
Last Updated: 09/26/2026